PHAT vs REGN: Which Stock is Better?
Side-by-side comparison of Phathom Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc in 2026
PHAT
Phathom Pharmaceuticals Inc
—
REGN
Regeneron Pharmaceuticals Inc
$662.88
Key Metrics Comparison
| Metric | PHAT | REGN | Winner |
|---|---|---|---|
| Market Cap | $622.74M | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PHAT
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAT or REGN a better investment?
Comparing PHAT and REGN: Phathom Pharmaceuticals Inc has a market cap of $622.74M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAT and REGN?
PHAT (Phathom Pharmaceuticals Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAT or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHAT or REGN?
Both PHAT and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PHAT or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PHAT or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $622.74M for PHAT.
Should I buy PHAT or REGN in 2026?
Both PHAT and REGN have investment merit. PHAT trades at $N/A while REGN trades at $662.88. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAT and REGN stock?
Key differences: Market Cap ($622.74M vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PHAT or REGN in 2026?
The choice between PHAT and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PHAT and REGN?
PHAT (Phathom Pharmaceuticals Inc) has a market cap of $622.74M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.